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Skeletal muscle atrophy: relationship between basic 
and applied sciences (Kinesiology/Physiotherapy)
Skeletal muscle atrophy occurs due to a decrease 
in the synthesis pathways and/or an increase in 
protein degradation pathways. Once the size of 
the muscle fiber is affected, the individual loses 
muscle mass and strength and, consequently, the 
functional capacity.
Molecular biology techniques show that, in 
a condition of skeletal muscular atrophy, such 
as muscle disuse of a bed-bound patient, the 
markers involved in protein degradation pathways 
increase significantly in the first days (1-3 days), 
but decrease afterwards. On the other hand, the 
markers involved in the protein synthesis pathways 
suffer a constant decrease over the days without 
anabolic stimulus, which, in the case of the subject 
on bed rest, would be the mechanical load1. When 
the degradation pathways prevail over the synthesis 
pathways, the result is the loss of skeletal muscle 
mass and a decrease in the functionality of the 
subject2,3.
As kinesiologists/physiotherapists, we see 
several conditions that can lead to a state of skeletal 
muscle atrophy, including: disuse, immobilization, 
catabolic diseases, such as cancer, or natural 
processes, such as aging. The effects may differ 
among the distinct causes of skeletal muscular 
atrophy, for example, young subjects submitted 
to seven days of immobilization had a loss of 220 
grams muscle mass in their immobilized lower 
limb as opposed to being seven days on bed rest, 
when they had a loss of 140 grams muscle mass 
in each lower limb (with greater total body muscle 
loss). This accounts for ~0.6% loss of muscle mass 
in the lower limb per day of atrophy. Additionally, 
muscle strength was affected even further, showing 
~1.3% loss per day4.
Recent scientific literature and international 
congresses mention the concept of “anabolic 
resistance,” which describes the reduction of 
skeletal muscle sensitivity/response to an anabolic 
stimulation. In general, this concept of “anabolic 
resistance” would be responsible, in part, for the 
typical loss of skeletal muscle mass in conditions 
such as disuse, aging and some diseases5. Several 
strategies have been used to counteract skeletal 
muscle atrophy: physical exercise, nutritional 
supplementation, electrical stimulation, among 
others. By measuring muscle protein synthesis in 
humans through muscle biopsy, resistance training 
has shown a greater potential to increase skeletal 
muscle mass. Moreover, the combination of physical 
exercise with an adequate nutritional protocol could 
increase those beneficial effects.
The evidences raised by basic sciences over the 
years, such as the ones mentioned above, show that 
kinesiologists/physiotherapists are indispensable 
from the first minute the subject is affected by skeletal 
muscular atrophy, such as entering an Intensive Care 
Unit or being partially/completely immobilized 
due to accident injuries. The rehabilitation practice 
should be intensified during conditions of disuse or 
immobilization in special populations (older adults, 
subjects with cancer or diabetes, among others), 
for those with a predisposition to develop skeletal 
muscle atrophy. Hence, the implementation of more 
hours of rehabilitation in different health facilities 
during the day, night and weekends is theoretically 
coherent, otherwise we will have subjects with a 
lower degree of functionality and, in the long run, 
greater functional dependency and health costs for 
the country.
The current recommendation for the 
aforementioned cases is to consume adequate 
amounts of proteins/amino acids, perform early 
stimulation using mechanical loading (through 
electrical stimulation, therapeutic exercise, 
ambulation, etc.) and increase, according to the 
conditions of the subject, the anabolic stimulus in 
special populations.
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